US Food and Drug Administration clears Utah spin-out BioFire's technology.

Nutrasorb will commercialise a new variety of lettuce.

Forendo, which is developing treatments for endometriosis and low testosterone, has closed its second round of funding.

TVM Capital Healthcare Partners has stated in plans to invest $200m in its companies over the next four year to expand across the Gulf Arab region and India.

The corporate-backed company, which is developing treatments for peanut and milk allergies, secured $92.6m after raising approximately $50m in venture funding.

Patient check-in platform Phreesia has raised $30m in an Ascension Health-backed series E round, bringing the total raised by the company to almost $75m.

Mayfield leads a $4.4m investment round in the mental health care startup.

Diabetes diagnostics app developer Telcare has now raised almost $70m in total after a series C round featuring Qualcomm, which made its third investment in the company.

Cellular immunotherapy company Unum Therapeutics has secured $12m in a series A round that included Sanofi-Genzyme BioVentures to further develop its cancer treatments.